~~<i id='C85675CC95'><strike id='C85675CC95'><tt id='C85675CC95'><pre id='C85675CC95'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

entertainment

author：hotspot 2025-08-19 18:06:49 - browse：798

The FDA has taken a big step in encouraging drug companies to include pregnant women in clinical trials, issuing a draft guidance outlining how to do so safely and ethically.

Nearly 4 million women in the U.S. give birth each year, but few drugs have been approved as safe and effective to use during pregnancy. The new guidance aims to help drug companies address those information gaps “through judicious inclusion of pregnant women in clinical trials and careful attention to potential fetal risk.”

Experts say it’s a sign of progress on an issue that’s long plagued pregnant women and their physicians.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： What it's like to live with paralysis for one psychologist

leisure time

Wikipedia

leisure time

focus

explore

hotspot

AdobeItisoneofhealthcare’smostvexingquandaries:Patientdatamustbesharedtodevelopmoreeffectivemedicine

WSS

The story of mRNA: From a loose idea to a tool that may help curb Covid

Democrats decry new health bill for going easy on private equity

Why we need to separate burnout from moral injury in health care

The battle over the Brookhaven Landfill on Long Island

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

What to watch for from Zogenix and Amicus clinical trials

hotspot

entertainment

leisure time

Alkermes shareholders re

In areas with more Black doctors, Black people live longer

Drug repurposing or repositioning? The language matters

How doctors’ personal politics affect patients

Supreme Court strikes down use of affirmative action

How doctors’ personal politics affect patients

Moonlake's readout produced a cash windfall. Risks remain

Weight bias in eating disorder treatment complicated by new weight loss drugs

The cancer drug shortage isn’t new — and neither are the solutions

UHS says company favors patients whose insurance pays more

Wikipedia

New guidelines on severe brain injury complicate already difficult decisions

The strategy behind pharma's lawsuits over drug pricing reform

Weight bias in eating disorder treatment complicated by new weight loss drugs

Will the FTC rein in IQVIA's health data empire?

Paxlovid study fails to answer questions over benefit for broader groups

Former reverend arrested for allegedly killing 8

leisure time

focus

explore

hotspot